Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tufman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 6, 2014
[Lung cancer]R M Huber, A Tufman
Technology in Cancer Research & Treatment|April 27, 2011
Organ-cocultures (COCs) for long term in vitro studies of lung cancer using 2-photon microscopyM Edelmann, A Tufman, R M Huber, et al.
European Review for Medical and Pharmacological Sciences|March 7, 2020
Identification of lung adenocarcinoma-specific exosome RNAs in peripheral blood by RNA-Seq analysisX-Q Liu, A Tufman, R Kiefl, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|August 7, 2010
GSH attenuates organ injury and improves function after transplantation of fatty liversS Pratschke, M K Angele, U Grützner, et al.
Allergy|May 18, 2017
Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approachK Milger, J Götschke, L Krause, et al.
ESMO Open|June 25, 2023
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementationJ R Gosney, L Paz-Ares, P Jänne, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trialS Peters, E Felip, U Dafni, et al.
ESMO Open|October 25, 2025
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinibN Peled, A Tufman, L V Sequist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2022
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)M Janning, J Süptitz, C Albers-Leischner, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|March 6, 2014
[Lung cancer]R M Huber, A Tufman
Technology in Cancer Research & Treatment|April 27, 2011
Organ-cocultures (COCs) for long term in vitro studies of lung cancer using 2-photon microscopyM Edelmann, A Tufman, R M Huber, et al.
European Review for Medical and Pharmacological Sciences|March 7, 2020
Identification of lung adenocarcinoma-specific exosome RNAs in peripheral blood by RNA-Seq analysisX-Q Liu, A Tufman, R Kiefl, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|August 7, 2010
GSH attenuates organ injury and improves function after transplantation of fatty liversS Pratschke, M K Angele, U Grützner, et al.
Allergy|May 18, 2017
Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approachK Milger, J Götschke, L Krause, et al.
ESMO Open|June 25, 2023
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementationJ R Gosney, L Paz-Ares, P Jänne, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trialS Peters, E Felip, U Dafni, et al.
ESMO Open|October 25, 2025
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinibN Peled, A Tufman, L V Sequist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2022
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)M Janning, J Süptitz, C Albers-Leischner, et al.
Pageof 1